Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Arris/Merck & Co. osteoporosis collaboration

Nov. 21, 1996

French market introduction for Fractal

Nov. 21, 1996

HRT for preserving bone density in postmenopausal women

Nov. 20, 1996

Immunoregulating effect of IL-4 in IDDM

Nov. 20, 1996

Pharming granted orphan drug status for Pompe's disease therapy

Nov. 20, 1996

Warner-Lambert claims lipid-regulating agents for vascular disease, diabetes

Nov. 20, 1996

FDA approves treatment for homocystinuria

Nov. 19, 1996

Growth stimulant reported by American Cyanamid

Nov. 19, 1996

Second NDA submitted for Crinone

Nov. 15, 1996

Lilly reports agents to treat menopause-related conditions

Nov. 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...